Document Detail


Model-specific selection of molecular targets for heart failure gene therapy.
MedLine Citation:
PMID:  21954055     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Heart failure (HF) is a complex multifaceted problem of abnormal ventricular function and structure. In recent years, new information has been accumulated allowing for a more detailed understanding of the cellular and molecular alterations that are the underpinnings of diverse causes of HF, including myocardial ischemia, pressure-overload, volume-overload or intrinsic cardiomyopathy. Modern pharmacological approaches to treat HF have had a significant impact on the course of the disease, although they do not reverse the underlying pathological state of the heart. Therefore gene-based therapy holds a great potential as a targeted treatment for cardiovascular diseases. Here, we survey the relative therapeutic efficacy of genetic modulation of β-adrenergic receptor signaling, Ca(2+) handling proteins and angiogenesis in the most common extrinsic models of HF.
Authors:
Michael G Katz; Anthony S Fargnoli; Catherine E Tomasulo; Louella A Pritchette; Charles R Bridges
Related Documents :
22546885 - Baseline q waves as a prognostic modulator in patients with st-segment elevation: insig...
10190375 - The association of chronic cough with the risk of myocardial infarction: the framingham...
22655285 - Familial xanthelasma with dyslipidemia: just another family trait?
11874605 - Indications for mechanical ventilation in adults with acute respiratory failure.
19434515 - What tissue bankers should know about the use of allograft heart valves.
3735655 - Atrial filling fraction obtained by aortic root echocardiogram in man.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Review    
Journal Detail:
Title:  The journal of gene medicine     Volume:  13     ISSN:  1521-2254     ISO Abbreviation:  J Gene Med     Publication Date:  2011 Oct 
Date Detail:
Created Date:  2011-10-25     Completed Date:  2012-02-23     Revised Date:  2013-06-27    
Medline Journal Info:
Nlm Unique ID:  9815764     Medline TA:  J Gene Med     Country:  England    
Other Details:
Languages:  eng     Pagination:  573-86     Citation Subset:  IM    
Copyright Information:
Copyright © 2011 John Wiley & Sons, Ltd.
Affiliation:
Department of Surgery, Division of Cardiovascular Surgery, The University of Pennsylvania Medical Center, Philadelphia, PA, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Disease Models, Animal
Genetic Therapy / methods*
Heart / physiopathology*
Heart Failure / genetics*,  physiopathology,  therapy*
Humans
Myocardial Ischemia / genetics,  physiopathology,  therapy
Receptors, Adrenergic, beta / genetics,  metabolism
Signal Transduction / physiology
Grant Support
ID/Acronym/Agency:
1-R01-HL083078-01A2/HL/NHLBI NIH HHS; P30-DK047757/DK/NIDDK NIH HHS; R01 HL083078/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Receptors, Adrenergic, beta
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Association between white matter microstructure, executive functions, and processing speed in older ...
Next Document:  Solvatochromic Effects on the Photoinduced Charge-Transfer States in Donor-Acceptor Substituted Poly...